201 related articles for article (PubMed ID: 30816596)
1. AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.
Pang M; Rodríguez-Gonzalez M; Hernandez M; Recinos CC; Seldeen KL; Troen BR
J Cell Biochem; 2019 Aug; 120(8):12382-12392. PubMed ID: 30816596
[TBL] [Abstract][Full Text] [Related]
2. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
3. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
[TBL] [Abstract][Full Text] [Related]
4. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.
Feng H; Cheng T; Steer JH; Joyce DA; Pavlos NJ; Leong C; Kular J; Liu J; Feng X; Zheng MH; Xu J
J Biol Chem; 2009 May; 284(21):14667-76. PubMed ID: 19321441
[TBL] [Abstract][Full Text] [Related]
5. Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene.
Guha M; Srinivasan S; Koenigstein A; Zaidi M; Avadhani NG
Ann N Y Acad Sci; 2016 Jan; 1364(1):52-61. PubMed ID: 25800988
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
7. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.
Sharma SM; Sif S; Ostrowski MC; Sankar U
J Cell Physiol; 2009 Jul; 220(1):230-7. PubMed ID: 19288495
[TBL] [Abstract][Full Text] [Related]
8. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
11. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
[TBL] [Abstract][Full Text] [Related]
12. Mitf regulates osteoclastogenesis by modulating NFATc1 activity.
Lu SY; Li M; Lin YL
Exp Cell Res; 2014 Oct; 328(1):32-43. PubMed ID: 25152440
[TBL] [Abstract][Full Text] [Related]
13. The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).
Bronisz A; Carey HA; Godlewski J; Sif S; Ostrowski MC; Sharma SM
J Biol Chem; 2014 Jan; 289(1):326-34. PubMed ID: 24257758
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-Jak3:Jak3 coexpressed pattern regulates monosodium urate crystal-induced osteoclast differentiation through Nfatc1/Ctsk expression.
Lee CP; Huang YN; Nithiyanantham S; Huang CM; Ko YC
Environ Toxicol; 2019 Feb; 34(2):179-187. PubMed ID: 30387921
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in enhancement of osteoclast formation by activin-A.
Kajita T; Ariyoshi W; Okinaga T; Mitsugi S; Tominaga K; Nishihara T
J Cell Biochem; 2018 Aug; 119(8):6974-6985. PubMed ID: 29737562
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase C accelerates murine osteoclastogenesis partly via transactivation of RANK gene through functional AP-1 responsive element in RANK gene promoter.
Kitazawa R; Kinto-Shibahara S; Haraguchi R; Kohara Y; Kitazawa S
Biochem Biophys Res Commun; 2019 Jul; 515(2):268-274. PubMed ID: 31146918
[TBL] [Abstract][Full Text] [Related]
17. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
18. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
20. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]